Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cengild Medical BhdXKLS:0243 57 3-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates XKLS:0243 with a GF Score™ of 57/100 and a GF Value™ of RM0.26 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 446 Healthcare Providers & Services companies, Cengild Medical Bhd ranks better than 60.31% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Cengild Medical Bhd's current 3-Year Share Buyback Ratio was 0.00%.
The historical rank and industry rank for Cengild Medical Bhd's 3-Year Share Buyback Ratio or its related term are showing as below:
During the past 9 years, Cengild Medical Bhd's highest 3-Year Share Buyback Ratio was 0.00%. The lowest was -0.60%. And the median was -0.30%.
XKLS:0243's 3-Year Share Buyback Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: -1.65 * Ranked among companies with meaningful 3-Year Share Buyback Ratio only.
Cengild Medical Bhd (XKLS:0243) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Cengild Medical Bhd 3-Year Share Buyback Ratio Related Terms
XKLS:0243 vs HCA, THC, EHC: 3-Year Share Buyback Ratio Comparison
For the Medical Care Facilities subindustry, Cengild Medical Bhd's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cengild Medical Bhd 3-Year Share Buyback Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Cengild Medical Bhd's 3-Year Share Buyback Ratio falls into.
Cengild Medical Bhd 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.00 mean?
Cengild Medical Bhd (XKLS:0243) has a 3-Year Share Buyback Ratio of 0.00 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Cengild Medical Bhd and its competitors. According to the industry distribution chart, Cengild Medical Bhd ranks #177 out of 446 companies in the Healthcare Providers & Services industry, placing it in the top 39.7%.
Is Cengild Medical Bhd's 3-Year Share Buyback Ratio too high?
Cengild Medical Bhd's current 3-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Cengild Medical Bhd ranks #177 out of 446 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cengild Medical Bhd has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's 3-Year Share Buyback Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cengild Medical Bhd ranks #177 out of 446 companies for 3-Year Share Buyback Ratio. This puts Cengild Medical Bhd in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 3-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Cengild Medical Bhd and its competitors. Cengild Medical Bhd's current 3-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.26, compared to a current price of RM0.20 — trading 25% below its estimated fair value. The current 3-Year Share Buyback Ratio is 0.00. Cengild Medical Bhd's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current 3-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.20 is trading 25% below its estimated GF Value™ of RM0.26.
GuruFocus considers Cengild Medical Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0243:
3-Year Share Buyback Ratio: 0.00
GF Value™: RM0.26 vs. price of RM0.20 (25% below fair value)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
57GF Score
Get the complete analysis for XKLS:0243
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
